Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Mimedx Group Inc (MDXG)
Mimedx Group Inc (MDXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
3 A-Rated Medical Stocks to Watch and Buy

The medical industry is set for significant growth due to technological advances, increased demand for medicines due to an aging population, escalating healthcare costs, and the rising need for quality...

GSK : 41.87 (-1.11%)
MDXG : 8.34 (+1.71%)
NHC : 97.87 (+0.05%)
3 Medical Stocks Set to Soar in 2024

The healthcare industry in 2024 is shaped by personalized medicine and innovative technologies in pharmacy, diagnostic testing, and medical devices. Hence, fundamentally strong medical stocks CVS Health...

A : 137.28 (+0.20%)
CVS : 74.04 (-1.53%)
MDXG : 8.34 (+1.71%)
3 Solid Medical Stocks to Watch for Year-End Success and Beyond

The medical sector is poised for significant growth, driven by technological advances, robust demand for medicines due to an aging population, escalating healthcare costs, and the rising need for quality...

ELV : 500.45 (-0.53%)
MDXG : 8.34 (+1.71%)
NATR : 17.81 (+1.04%)
3 Medical Stocks Diagnosing Weekly Profit Potential

The healthcare industry is experiencing rapid transformation and is well-positioned to thrive due to the rising demand for high-quality healthcare and medical device innovation. Hence, fundamentally strong...

CAH : 111.53 (-0.12%)
MDXG : 8.34 (+1.71%)
NATR : 17.81 (+1.04%)
3 Medical Stocks Elevating Investors' Profit Potential

Within the rapidly evolving healthcare landscape, opportunities arise from operational improvements, making the sector poised for significant expansion. Hence, fundamentally strong medical stocks Cardinal...

CAH : 111.53 (-0.12%)
FSNUY : 6.9780 (-0.46%)
MDXG : 8.34 (+1.71%)
Henry Schein (HSIC) Q3 Earnings Analysis: A Medical Stock to Watch?

Henry Schein (HSIC) posted solid third-quarter 2023 sales growth and non-GAAP EPS growth despite continued lower sales of PPE products and COVID-19 test kits. In addition, the company’s long-term outlook...

FONR : 23.00 (unch)
HSIC : 76.62 (+0.17%)
MDXG : 8.34 (+1.71%)
OCPNY : 18.0000 (-1.37%)
Assessing Alcon Inc.’s (ALC) Post-Earnings Prospects: Is It Time to Invest, Hold, or Let Go?

Is Swiss eye care leader Alcon Inc. (ALC) a buy, hold, or sell after its third-quarter earnings release yesterday? Let’s look at its financial metrics to gauge its prospects… Geneva, Switzerland-based...

ALC : 84.77 (-1.07%)
FONR : 23.00 (unch)
MDXG : 8.34 (+1.71%)
VREX : 17.15 (+0.76%)
Becton Dickinson & Co. (BDX) Earnings Moves: A Buy or Sell for Investors?

Becton Dickinson & Co. (BDX) is expected to report steady growth for its fiscal fourth quarter ended September 2023, scheduled to be released on November 9. While the stock is witnessing weakness over...

BDX : 235.64 (-1.47%)
ELMD : 15.13 (-1.88%)
FONR : 23.00 (unch)
MDXG : 8.34 (+1.71%)
Are These 3 Medical Stocks a Safe Investment?

The future of the medical devices and equipment industry looks buoyant, given rising chronic conditions and the adoption of advanced technology. Given this backdrop, would it be prudent for investors to...

HAE : 72.65 (-2.97%)
MDXG : 8.34 (+1.71%)
TRUMY : 38.8300 (+0.28%)
MiMedx Group (NASDAQ: MDXG) Reports Q1 2023 Financial Results Showing 21.7% Sales Growth

MiMedx Group, Inc. (NASDAQ: MDXG) is engaged as a biotechnology company that is focused as a placental biologics developer to

MDXG : 8.34 (+1.71%)

Barchart Exclusives

Ride Disney’s Unusual Options Activity All the Way to $200
Walt Disney stock is up more than 22% in 2024. However, it remains well below its March 2021 all-time high of $203.02. Recent unusual options activity suggests there’s a bet to be made as it steers a course to get back there. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar